Medications

Stakes are high ahead of FDA panel vote on ALS drug

Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for the deadly neurological disease ALS (amyotrophic lateral sclerosis), with a decision expected this week.

Genetics

Silencing a faulty gene may uncover clues to rare forms of ALS

Using an experimental drug, researchers have been able to suppress a mutated amyotrophic lateral sclerosis (ALS) gene. Studies in mice demonstrate that the therapy could show promise in treating rare, aggressive forms of ...

page 2 from 7